Summary
The product BPC-157 5 mg, manufactured by Biogenix Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number Unknown, was submitted by the reseller biogenixpharma and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of BPC-157, with a concentration of 4.99 mg, aligning almost exactly with the labeled claim of 5 mg. The product’s purity was determined to be 98.061%.
The testing process began on 11 August 2024, with the sample received on 22 August 2024, and analysis completed on 23 August 2024. While the results confirm accurate dosing and high purity, scrutiny of reseller-submitted samples remains essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Biogenix Pharma
- Product Name: BPC-157 5 mg
- Active Ingredient: BPC-157
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #47818
- Testing Ordered: 11 August 2024
- Sample Received: 22 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: biogenixpharma (Reseller)
- Analysis Paid For By: biogenixpharma
Testing Results
- Specification: 5 mg (as stated on the label)
- Measured Concentration: 4.99 mg
- Accuracy: 99.8% (0.2% below the label claim)
- Purity: 98.061%
Verification Details
- Verification URL: https://janoshik.com/tests/47818_WI2B8D9HW3CJ
Evaluation of Reseller-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the reseller biogenixpharma. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that BPC-157 5 mg is almost perfectly dosed, with a measured concentration of 4.99 mg, and maintains a high purity of 98.061%. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding peptide products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
